Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
OKYO.L Stock Summary
In the News
OKYO.L Financial details
Company Rating
Sell
Market Cap
23.22M
Income
-1.21M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
7
Optionable
No
Shortable
Yes
Earnings
14 Aug 2023
P/E
-4.22
Forward P/E
-
PEG
0.9
P/S
-
P/B
7.78
P/C
-
P/FCF
-7.1
Quick Ratio
2.65
Current Ratio
3.17
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-6.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-126%
ROE
-136%
ROC
-2.11%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
1.66B
Shs Float
8.54M
-
-
-
-
Target Price
-
52W Range
0.0-8.5
52W High
-
52W Low
-
RSI
-
Rel Volume
0.04
Avg Volume
538.14K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-0.061508
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
OKYO.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.14 | -0.01 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0.01 | 0 | 0 | 0.01 | 0 | |
Book value per share | 0.01 | 0 | 0 | 0.01 | 0 | |
Tangible book value per share | 0.01 | 0 | 0 | 0.01 | 0 | |
Share holders equity per share | 0.01 | 0 | 0 | 0.01 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 8.4M | 6.17M | 10.12M | 53.82M | 63.65M | |
Enterprise value | 6.39M | 5.69M | 9.96M | 48.9M | 61.59M | |
P/E ratio | -0.16 | -1.64 | -8.34 | -17.96 | -15.39 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -8.44 | -4.04 | -9.5 | -43.23 | -15.29 | |
PFCF ratio | -8.44 | -4.04 | -9.5 | -43.06 | -15.29 | |
P/B Ratio | 4.38 | 24.14 | -89.57 | 13.96 | 28.37 | |
PTB ratio | 4.38 | 24.14 | -89.57 | 13.96 | 28.37 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -0.12 | -1.51 | -8.55 | -16.32 | -13.02 | |
EV to operating cash flow | -6.42 | -3.73 | -9.35 | -39.28 | -14.8 | |
EV to free cash flow | -6.42 | -3.72 | -9.35 | -39.12 | -14.79 | |
Earnings yield | -6.33 | -0.61 | -0.12 | -0.06 | -0.06 | |
Free cash flow yield | -0.12 | -0.25 | -0.11 | -0.02 | -0.07 | |
Debt to equity | 0 | 0 | -0.23 | 0.02 | 0 | |
Debt to assets | 0 | 0 | 0.05 | 0.01 | 0 | |
Net debt to EBITDA | 0.04 | 0.13 | 0.14 | 1.64 | 0.43 | |
Current ratio | 22.05 | 1.78 | 0.8 | 4.09 | 3.17 | |
Interest coverage | 0 | 0 | -1.32K | -3.5K | 0 | |
Income quality | 0.02 | 0.41 | 0.84 | 0.41 | 0.88 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | -6.07 | 0 | -0.5 | -0.72 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.13 | 0.01 | 0 | 0.02 | 0.01 | |
ROIC | -0.44 | -14.62 | 18.58 | -0.75 | -1.84 | |
Return on tangible assets | -26.47 | -6.45 | -2.51 | -0.58 | -1.26 | |
Graham Net | 0.01 | 0 | 0 | 0.01 | 0 | |
Working capital | 1.92M | 254.57K | -116.35K | 3.83M | 2.24M | |
Tangible asset value | 1.92M | 255.42K | -113.02K | 3.85M | 2.24M | |
Net current asset value | 1.92M | 254.57K | -137.81K | 3.78M | 2.24M | |
Invested capital | 0 | 0 | -0.23 | 0.02 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 336.27K | |
Average payables | 73.69K | 146.35K | 386.33K | 316.42K | 358.79K | |
Average inventory | 0 | 0 | 0 | 0 | -84.89K | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -27.73 | -14.72 | 10.75 | -0.78 | -1.84 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q2
Metric | History | 2020-09-30 | 2021-03-31 | 2021-09-30 | 2022-03-31 | 2022-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0.01 | 0 | 0 | 0 | 0 | |
Book value per share | 0.01 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0.01 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0.01 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 48.82M | 0 | 0 | 0 | 0 | |
Enterprise value | 43.08M | -4.92M | -3.79M | -2.06M | -633.63K | |
P/E ratio | -40.2 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -183.28 | 0 | 0 | 0 | 0 | |
PFCF ratio | -183.28 | 0 | 0 | 0 | 0 | |
P/B Ratio | 8.88 | 0 | 0 | 0 | 0 | |
PTB ratio | 8.88 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -135.82 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | -161.73 | 0 | 0 | 0 | 0 | |
EV to free cash flow | -161.73 | 0 | 0 | 0 | 0 | |
Earnings yield | -0.01 | 0 | 0 | 0 | 0 | |
Free cash flow yield | -0.01 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.02 | 0.02 | 0 | 0 | |
Debt to assets | 0 | 0.01 | 0.01 | 0 | 0 | |
Net debt to EBITDA | 18.09 | 0 | 0 | 0 | 0 | |
Current ratio | 17.94 | 4.09 | 8.95 | 3.17 | 0.83 | |
Interest coverage | -1.32K | 0 | 0 | 0 | 0 | |
Income quality | 0.88 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.01 | 0 | 0 | 0 | 0 | |
ROIC | -0.05 | 0 | 0 | 0 | 0 | |
Return on tangible assets | -0.05 | 0 | 0 | 0 | 0 | |
Graham Net | 0.01 | 0 | 0 | 0 | 0 | |
Working capital | 5.49M | 3.83M | 3.65M | 2.24M | -314.71K | |
Tangible asset value | 5.5M | 3.85M | 3.68M | 2.24M | -309.68K | |
Net current asset value | 5.47M | 3.78M | 3.62M | 2.24M | -314.71K | |
Invested capital | 0 | 0.02 | 0.02 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.06 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
OKYO.L Frequently Asked Questions
What is OKYO Pharma Limited stock symbol ?
OKYO Pharma Limited is a GB stock and trading under the symbol OKYO.L
What is OKYO Pharma Limited stock quote today ?
OKYO Pharma Limited stock price is $- today.
Is OKYO Pharma Limited stock public?
Yes, OKYO Pharma Limited is a publicly traded company.